TITLE

Serologic Response to Inactivated Poliovirus Vaccine: A Randomized Clinical Trial Comparing 2 Vaccination Schedules in Puerto Rico

AUTHOR(S)
Dayan, Gustavo H.; Thorley, Margaret; Yamamura, Yasuhiro; Rodríguez, Nayra; McLaughlin, Steve; Torres, Lourdes M.; Seda, Antonio; Carbia, Marcia; Alexander, Lorraine N.; Caceres, Victor; Pallansch, Mark A.
PUB. DATE
January 2007
SOURCE
Journal of Infectious Diseases;1/1/2007, Vol. 195 Issue 1, p12
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background. The World Health Organization (WHO) recommends the discontinuation of oral poliovirus vaccine after eradication of wild poliovirus. Studies assessing inactivated poliovirus vaccine (IPV) immunogenicity tropical countries, using the WHO Expanded Programme on Immunization (EPI) schedule, have been limited. Methods. We conducted a randomized clinical trial in Ponce, Puerto Rico. Infants were assigned to 1 of 2 study arms: those in the EPI arm received IPV at 6, 10, and 14 weeks of age, and those in the US arm received IPV at 2, 4, and 6 months of age. Neutralizing antibody titers against poliovirus types 1, 2, and 3 were tested on serum specimens obtained before administration of the first dose of IPV and 28-45 days after administration of the last dose of IPV. Results. Seroconversion rates for the EPI (n = 225) and US (n = 230) arms, respectively, were 85.8% and 99.6% for poliovirus type 1 (P < .001), 86.2% and 100% for poliovirus type 2 (P < .001), and 96.9% and 99.1% for poliovirus type 3 (P = .08). Seroconversion rates were lower among infants in the EPI arm who had high maternal antibody levels for all 3 poliovirus types (P < .001). Conclusions. The EPI schedule resulted in lower seroconversion rates for poliovirus types 1 and 2. These results are relevant for tropical countries planning to use IPV in a posteradication environment.
ACCESSION #
23305067

 

Related Articles

  • Progress Toward Laboratory Containment of Poliovirus After Polio Eradication. Wolff, Christopher; Roesel, Sigrun; Lipskaya, Galina; Landaverde, Mauricio; Humayun, Asghar; Withana, Nalini; Ramamurty, Nalini; Tomori, Oyewale; Okiror, Samuel Oumo; Salla, Mbaye; Dowdle, Walter // Journal of Infectious Diseases;Nov2014 Supplement, Vol. 210 Issue suppl_1, pS454 

    Background. The first steps (phase 1) toward laboratory containment of poliovirus after eradication are a national survey of biomedical facilities and a global inventory of such facilities retaining wild poliovirus (WPV) infectious and potentially infectious materials.Methods. We reviewed...

  • Adverse events monitoring as a routine component of vaccine clinical trials: Evidence from the... Mayans, Marti Vall; Robertson, Susan E. // Bulletin of the World Health Organization;2000, Vol. 78 Issue 9, p1166 

    Reports on the use of the World Health Organization (WHO) Vaccine Trial Registry to assess whether and how investigators are monitoring adverse events following immunization (AEFI) in vaccine trials. Objective of the WHO Immunization Safety Priority; AEFI according to reports; Points for...

  • Adverse events monitoring as a routine component of vaccine clinical trials: Evidence from the... Mayans, Marti Vall; Robertson, Susan E. // Bulletin of the World Health Organization;2000, Vol. 78 Issue 9, p1166 

    Reports on the use of the World Health Organization (WHO) Vaccine Trial Registry to assess whether and how investigators are monitoring adverse events following immunization (AEFI) in vaccine trials. Objective of the WHO Immunization Safety Priority; AEFI according to reports; Points for...

  • Best of times, worst of times.  // Nature Reviews Microbiology;Jun2014, Vol. 12 Issue 6, p391 

    An introduction is presented in which the editor discusses various reports within the issue on topics including poliovirus, vaccination of children, and World Health Organization (WHO).

  • POTENTIAL FOR CIRCULATION OF VACCINE-DERIVED POLIOVIRUSES. Minor, Philip // Vaccines: Preventing Disease & Protecting Health;2004, p31 

    Information on issues related to vaccine-derived polioviruses from a chapter of the book "Vaccines: Preventing Diseases & Protecting Health" is presented. The capability of polio vaccines to change on replication in the human gut is elaborated and the outbreak of poliomyelitis on the island of...

  • 2005 Poliovirus eradication: poliovirus presence in Cyprus 2 years after. Richter, Jan; Bashiardes, Stavros; Koptides, Dana; Tryfonos, Christina; Pissarides, Nikolas; Stavrou, Niki; Papageorgiou, Georgos T.; Christodoulou, Christina // Water Science & Technology;2008, Vol. 58 Issue 3, p647 

    The last case of polio in Cyprus caused by a wild-type poliovirus occurred in 1995. Since then Cyprus belongs to the countries considered poliovirus-free by the WHO. The aim of this study was to confirm the absence of any circulating wild-type polioviruses and to monitor vaccine-derived...

  • Poliovirus in South Sudan and Madagascar.  // African Business News;11/14/2014, p1 

    No abstract available.

  • Immunogenicity and safety of a DTaP-IPV//PRP̃T combination vaccine given with hepatitis B vaccine: a randomized open-label trial. Capeding, Maria Rosario; Cadorna-Carlos, Josefina; Book-Montellano, May; Ortiz, Esteban // Bulletin of the World Health Organization;Jun2008, Vol. 86 Issue 6, p443 

    Objective To determine seroprotection and vaccine response rates produced by a diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae type-b conjugate (DTaP-IPV//PRP~T) vaccine containing a polyribosyl-ribitol-phosphate (PRP)-tetanus toxoid conjugate...

  • Vaccine formulation and delivery device.  // WHO Technical Report Series;2004, Issue 927, p52 

    The article presents the section of the World Health Organization guidelines on nonclinical evaluation of vaccines concerning vaccine formulation and the delivery device. The delivery device and vaccine development whether in liquid form, capsules or powder, can have an affect on the process of...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics